PleoPharma, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder (NCT07644052) | PleoPharma, Inc. | 2026-06-17 |
| Effect of PP-01 on Cannabis Withdrawal Syndrome (NCT05494437) | PleoPharma, Inc. | 2022-10-27 |
Track PleoPharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.